303 related articles for article (PubMed ID: 28509296)
1. Renal biopsy cases in myeloproliferative neoplasms (MPN).
Fujita K; Hatta K
CEN Case Rep; 2013 Nov; 2(2):215-221. PubMed ID: 28509296
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Fibrosis in Polycystic Kidney Disease.
Song CJ; Zimmerman KA; Henke SJ; Yoder BK
Results Probl Cell Differ; 2017; 60():323-344. PubMed ID: 28409351
[TBL] [Abstract][Full Text] [Related]
3. Reticulocyte hemoglobin content.
Mast AE; Blinder MA; Dietzen DJ
Am J Hematol; 2008 Apr; 83(4):307-10. PubMed ID: 18027835
[TBL] [Abstract][Full Text] [Related]
4. Letter to the editor concerning the article "Renal endarteritis with acute endocapillary proliferative glomerulonephritis" by Kawaguchi et al., Clin Nephrol. 2012; 77: 151-155 and authors response.
Iwafuchi Y; Morita T; Kamimura A
Clin Nephrol; 2012 Nov; 78(5):423-4. PubMed ID: 23084337
[No Abstract] [Full Text] [Related]
5. The differential diagnosis of classical myeloproliferative neoplasms (MPN): the updated WHO criteria.
Kvasnicka HM
Rinsho Ketsueki; 2019; 60(9):1166-1175. PubMed ID: 31597840
[TBL] [Abstract][Full Text] [Related]
6. The acute effects of intravenous frusemide on the renal kallikrein kinin system in man: relationship to dose.
Bicknell C; Campbell S; Waller D; Albano J
Immunopharmacology; 1996 May; 32(1-3):122-4. PubMed ID: 8796287
[TBL] [Abstract][Full Text] [Related]
7. Renal Fanconi syndrome: taking a proximal look at the nephron.
Klootwijk ED; Reichold M; Unwin RJ; Kleta R; Warth R; Bockenhauer D
Nephrol Dial Transplant; 2015 Sep; 30(9):1456-60. PubMed ID: 25492894
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytosis and Thrombosis: Is There Really a Correlation?
Galvez C; Stein BL
Curr Hematol Malig Rep; 2020 Aug; 15(4):261-267. PubMed ID: 32399765
[TBL] [Abstract][Full Text] [Related]
9. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
10. Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.
Brabrand M; Hansen KN; Laursen CB; Larsen TS; Vestergaard H; Abildgaard N
Eur J Haematol; 2019 Mar; 102(3):227-234. PubMed ID: 30450659
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate use in rheumatoid arthritis. A Clinician's perspective.
Alarcón GS
Immunopharmacology; 2000 May; 47(2-3):259-71. PubMed ID: 10878293
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.
Santambrogio L; Rammensee HG
Immunogenetics; 2019 Mar; 71(3):203-216. PubMed ID: 30343358
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy.
Javorniczky NR; Wehrle J; Ihorst G; Hupfer V; Aumann K; Pfeifer D; Niemöller C; Bleul S; Pantic M; Werner M; Duyster J; Finke J; Engelhardt M; von Bubnoff N; Waller CF; Pahl HL; Becker H
Leuk Res; 2020 Nov; 98():106454. PubMed ID: 32971364
[TBL] [Abstract][Full Text] [Related]
14. Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Ferreira Cristina S; Polo B; Lacerda JF
Semin Hematol; 2018 Oct; 55(4):215-222. PubMed ID: 30502850
[TBL] [Abstract][Full Text] [Related]
15. Lung metastases from benign uterine leiomyoma: does 18-FDG-PET/CT have a role to play?
Abu Saadeh F; Riain CO; Cormack CM; Gleeson N
Ir J Med Sci; 2019 May; 188(2):619-624. PubMed ID: 30074141
[TBL] [Abstract][Full Text] [Related]
16. Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey.
Koren-Michowitz M; Lavi N; Ellis MH; Vannucchi AM; Mesa R; Harrison CN
Ann Hematol; 2017 Jan; 96(1):87-92. PubMed ID: 27734130
[TBL] [Abstract][Full Text] [Related]
17. Hormonal and Reproductive Factors and Risk of Myeloproliferative Neoplasms in Postmenopausal Women.
Leal AD; Thompson CA; Wang AH; Vierkant RA; Habermann TM; Ross JA; Mesa RA; Virnig BA; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):151-7. PubMed ID: 26564251
[TBL] [Abstract][Full Text] [Related]
18. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
Mesa R; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Boyle J; Mascarenhas JO
BMC Cancer; 2016 Feb; 16():167. PubMed ID: 26922064
[TBL] [Abstract][Full Text] [Related]
19. MSC-based therapies in solid organ transplantation.
Benseler V; Obermajer N; Johnson CL; Soeder Y; Dahlke MD; Popp FC
Hepatol Int; 2014 Apr; 8(2):179-84. PubMed ID: 26202500
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
